Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pterodontic acid derivatives as well as preparation method and application thereof

A technology of malodotanic acid and its derivatives, applied in the field of natural medicinal chemistry, can solve the problems of large toxic side effects and easy complications

Pending Publication Date: 2020-11-24
YUNNAN UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, synthetic drugs have greater toxic and side effects on the body, which can easily cause complications, or other diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pterodontic acid derivatives as well as preparation method and application thereof
  • Pterodontic acid derivatives as well as preparation method and application thereof
  • Pterodontic acid derivatives as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0089] The synthesis of the 13 amidation derivatives of embodiment 1 malidan acid

[0090] Reaction (i) is carried out in the present embodiment: 50.0 mg of fendanic acid with the structure of formula (A) is dissolved in 5.0 mL of anhydrous dichloromethane (DCM) solvent, and 1-ethyl-(3-dimethyl Aminopropyl) carbodiimide hydrochloride (EDCI, 0.27mmol) as condensation agent, 4-dimethylaminopyridine (DMAP) catalyst (0.1mmol), add 0.25mmol methylamine hydrochloride, ethylamine hydrochloride salt, allylamine, dimethylamine hydrochloride, diethylamine hydrochloride, diallylamine, 2,4-dimethylhexylamine, cyclohexylamine, 2-methyl-2 imidazoline, 4-picolylamine, 4-methoxybenzylamine, 3-aminobenzylamine, methylbenzylamine, 3-chlorobenzylamine, 4-chlorobenzylamine, 4-fluorobenzylamine, 4-bromobenzylamine, 4-Hydroxybenzylamine, diphenylmethylamine, benzylamine, 4-methylbenzylamine, phenethylamine, 2-furylmethylamine, 4-(trifluoromethyl)benzylamine, 3-( Trifluoromethyl)benzylamine, 2-chl...

Embodiment 2

[0091] Synthesis of the 13-position amidation derivatives of embodiment 2 malidanic acid

[0092] Reaction (i) is carried out in the present embodiment: 80.0 mg of fendanic acid of formula (A) structure is dissolved in 8.0 mL of anhydrous dichloromethane (DCM) solvent, and 1-ethyl-(3-dimethyl Aminopropyl) carbodiimide hydrochloride (EDCI, 0.43mmol) as condensation agent, 4-dimethylaminopyridine (DMAP) catalyst (0.2mmol), add 0.40mmol methylamine hydrochloride, ethylamine hydrochloride salt, allylamine, dimethylamine hydrochloride, diethylamine hydrochloride, diallylamine, 2,4-dimethylhexylamine, cyclohexylamine, 2-methyl-2 imidazoline, 4-picolylamine, 4-methoxybenzylamine, 3-aminobenzylamine, methylbenzylamine, 3-chlorobenzylamine, 4-chlorobenzylamine, 4-fluorobenzylamine, 4-bromobenzylamine, 4-Hydroxybenzylamine, diphenylmethylamine, benzylamine, 4-methylbenzylamine, phenethylamine, 2-furylmethylamine, 4-(trifluoromethyl)benzylamine, 3-( Trifluoromethyl)benzylamine, 2-chlor...

Embodiment 3

[0093] Synthesis of the 13 amidation derivatives of embodiment 3 malidanic acid

[0094] Reaction (i) is carried out in the present embodiment: 60.0 mg of meridanic acid of formula (A) structure is dissolved in 6.0 mL of anhydrous dichloromethane (DCM) solvent, and 1-ethyl-(3-dimethyl Aminopropyl) carbodiimide hydrochloride (EDCI, 0.3mmol) as condensation agent, 4-dimethylaminopyridine (DMAP) catalyst (0.15mmol), add 0.35mmol methylamine hydrochloride, ethylamine hydrochloride salt, allylamine, dimethylamine hydrochloride, diethylamine hydrochloride, diallylamine, 2,4-dimethylhexylamine, cyclohexylamine, 2-methyl-2 imidazoline, 4-picolylamine, 4-methoxybenzylamine, 3-aminobenzylamine, methylbenzylamine, 3-chlorobenzylamine, 4-chlorobenzylamine, 4-fluorobenzylamine, 4-bromobenzylamine, 4-Hydroxybenzylamine, diphenylmethylamine, benzylamine, 4-methylbenzylamine, phenethylamine, 2-furylmethylamine, 4-(trifluoromethyl)benzylamine, 3-( Trifluoromethyl)benzylamine, 2-chlorobenzyla...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to pterodontic acid derivatives as well as a preparation method and application thereof, and belongs to the technical field of natural pharmaceutical chemistry. A series of pterodontic acid derivatives including C-5, C-12 and C-13 derivatives and the like are prepared by the method. The pterodontic acid derivatives prepared by the method have the advantages of being good in influenza A H1N1 virus resisting effect, good in stability, high in yield and the like. The derivatives play an important role in preparing medicines for treating virus infectious diseases such as influenza and the like. Meanwhile, the preparation method is simple and easy to implement, high in universality and easy to apply and popularize, and the yield of derivatives is larger than or equal to 80%.

Description

technical field [0001] The invention belongs to the technical field of natural medicinal chemistry, and in particular relates to a malidan acid derivative and its preparation method and application. Background technique [0002] Influenza virus is a kind of specific respiratory virus. It is an Orthomyxoviridae RNA virus that causes influenza in humans and poultry. Because its internal antigens are prone to change, it mutates and spreads, and there is seasonal transmission, so it is susceptible The population is concentrated in children and the elderly, and the infection mortality rate of the elderly with chronic diseases is relatively high. Influenza viruses are divided into three types: A, B, and C according to their internal proteins and antigens. Among them, influenza A virus is the type that mutates most frequently, which brings difficulties to prevention and control. Influenza A virus is divided into 18 different HA subtypes and 11 different NA subtypes according to it...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C233/10C07C233/21C07C231/02C07C233/39C07C233/13C07C233/91C07C279/22C07C277/08C07C69/608C07C67/08C07C21/215C07C17/093C07C211/27C07C209/16C07C247/10C07C309/65C07C303/24C07D401/04C07D249/06C07D295/03C07D303/40C07D295/185C07D233/06C07D213/40C07D307/92A61P31/16
CPCC07C233/10C07C233/21C07C233/39C07C233/13C07C233/91C07C279/22C07C69/608C07C21/215C07C211/27C07C247/10C07C309/65C07D401/04C07D249/06C07D295/03C07D303/40C07D295/185C07D233/06C07D213/40C07D307/92A61P31/16C07C2602/28C07C2601/14
Inventor 张荣平于浩飞胡炜彦黄邦连张兰春王新华李鲜周宁娜杨为民罗晓东赵昱胡建林刘绍兴王玉涛
Owner YUNNAN UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com